Vanda Pharmaceuticals Inc.
DE ˙ DB ˙ US9216591084
5,26 € ↑0,09 (1,74%)
2026-06-05
DEL PRIS
SecurityDE:VM4 / Vanda Pharmaceuticals Inc.
InstitutionJane Street Group, Llc
Latest Disclosed Ownership210,243 shares
Latest Disclosed Value $ 1,452,779
Jane Street Group, Llc ownership in VM4 / Vanda Pharmaceuticals Inc.

On May 12, 2026 - Jane Street Group, Llc filed a 13F-HR form disclosing ownership of 210,243 shares of Vanda Pharmaceuticals Inc. (DE:VM4) valued at $1,208,897 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 12, 2026 disclosing 49,641 shares of Vanda Pharmaceuticals Inc.. This represents a change in shares of 323.53% during the quarter. The current value of the position is $1,105,878 USD.

Jane Street Group, Llc has a history of taking positions in derivatives of the underlying security (VM4) in the form of stock options. The firm currently holds call options representing 37,400 of underlying shares valued at $258,434 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

DE:VM4 / Vanda Pharmaceuticals Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-12 2026-03-31 13F VANDA PHARMACEUTICALS COM 921659108 210,243 160,602 323.53 1,453 232.27 0.0001
2026-02-12 2025-12-31 13F VANDA PHARMACEUTICALS COM 921659108 49,641 -109,429 -68.79 438 -44.89 0.0001
2025-11-14 2025-09-30 13F VANDA PHARMACEUTICALS COM 921659108 159,070 79,963 101.08 794 112.60 0.0001
2025-08-14 2025-06-30 13F VANDA PHARMACEUTICALS COM 921659108 79,107 17,833 29.10 373 32.74 0.0001
2025-05-19 2025-03-31 13F/A-1 VANDA PHARMACEUTICALS COM 921659108 61,274 37,661 159.49 281 148.67 0.0001
2025-05-14 2025-03-31 13F VANDA PHARMACEUTICALS COM 921659108 61,274 37,661 281 0.0001
2025-02-14 2024-12-31 13F VANDA PHARMACEUTICALS COM 921659108 23,613 -41,678 -63.83 113 -63.07 0.0000
2024-11-15 2024-09-30 13F VANDA PHARMACEUTICALS COM 921659108 65,291 -45,605 -41.12 306 -51.12 0.0001
2024-08-15 2024-06-30 13F VANDA PHARMACEUTICALS COM 921659108 110,896 48,992 79.14 627 146.46 0.0001
2024-05-16 2024-03-31 13F VANDA PHARMACEUTICALS COM 921659108 61,904 -31,311 -33.59 254 -35.37 0.0001
2024-02-15 2023-12-31 13F VANDA PHARMACEUTICALS COM 921659108 93,215 -149,541 -61.60 393 -62.50 0.0001
2023-11-15 2023-09-30 13F VANDA PHARMACEUTICALS COM 921659108 242,756 199,963 467.28 1,049 271.63 0.0003
2023-08-14 2023-06-30 13F VANDA PHARMACEUTICALS COM 921659108 42,793 42,793 282 0.0001
2022-02-15 2021-12-31 13F VANDA PHARMACEUTICALS COM 921659108 0 -10,743 -100.00 0 -100.00
2021-11-16 2021-09-30 13F VANDA PHARMACEUTICALS COM 921659108 10,743 408 3.95 184 -17.12 0.0001
2021-08-16 2021-06-30 13F VANDA PHARMACEUTICALS COM 921659108 10,335 -7,422 -41.80 222 -16.85 0.0001
2021-05-18 2021-03-31 13F VANDA PHARMACEUTICALS COM 921659108 17,757 -2,549 -12.55 267 0.00 0.0001
2021-02-17 2020-12-31 13F VANDA PHARMACEUTICALS COM 921659108 20,306 -13,353 -39.67 267 -18.10 0.0001
2020-11-17 2020-09-30 13F VANDA PHARMACEUTICALS COM 921659108 33,659 33,659 65.76 326 22.10 0.0002
2020-05-15 2020-03-31 13F VANDA PHARMACEUTICALS COM 921659108 0 -23,414 -100.00 0 -100.00
2020-02-14 2019-12-31 13F VANDA PHARMACEUTICALS COM 921659108 23,414 23,414 384 0.0005
2018-08-15 2018-06-30 13F VANDA PHARMACEUTICALS COM 921659108 0 -15,282 -100.00 0 -100.00
2018-05-15 2018-03-31 13F VANDA PHARMACEUTICALS COM 921659108 15,282 -6,905 -31.12 258 -17.04 0.0007
2017-05-15 2017-03-31 13F VANDA PHARMACEUTICALS COM 921659108 22,187 -3,960 -15.15 311 -25.42 0.0014
2017-02-15 2016-12-31 13F VANDA PHARMACEUTICALS COM 921659108 26,147 -4,048 -13.41 417 -17.10 0.0018
2016-11-14 2016-09-30 13F VANDA PHARMACEUTICALS COM 921659108 30,195 12,322 68.94 503 151.50 0.0024
2016-08-15 2016-06-30 13F VANDA PHARMACEUTICALS COM 921659108 17,873 17,873 -40.81 200 -60.24 0.0010
2015-08-14 2015-06-30 13F VANDA PHARMACEUTICALS COM 921659108 0 -15,454 -100.00 0 -100.00
2015-05-11 2015-03-31 13F VANDA PHARMACEUTICALS COM 921659108 15,454 0 0.00 221 0.00 0.0017
2015-02-17 2014-12-31 13F VANDA PHARMACEUTICALS COM 921659108 15,454 -17,709 -53.40 221 -35.76 0.0017
2014-11-14 2014-09-30 13F VANDA PHARMACEUTICALS COM 921659108 33,163 33,163 114.59 344 55.66 0.0035
2014-08-14 2014-06-30 13F VANDA PHARMACEUTICALS COM 921659108 0 -16,144 -100.00 0 -100.00
2014-05-15 2014-03-31 13F VANDA PHARMACEUTICALS COM 921659108 16,144 16,144 262 0.0029
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-12 2026-03-31 13F VANDA PHARMACEUTICALS COM Call 37,400 -55.90 258 -65.46 n/a n/a n/a
2026-02-12 2025-12-31 13F VANDA PHARMACEUTICALS COM Call 84,800 748 n/a n/a n/a
2025-08-14 2025-06-30 13F VANDA PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2025-05-19 2025-03-31 13F/A VANDA PHARMACEUTICALS COM Call 13,300 61 n/a n/a n/a
2025-05-14 2025-03-31 13F VANDA PHARMACEUTICALS COM Call 13,300 61 n/a n/a n/a
2025-02-14 2024-12-31 13F VANDA PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2024-11-15 2024-09-30 13F VANDA PHARMACEUTICALS COM Call 15,200 71 n/a n/a n/a
2023-05-15 2023-03-31 13F VANDA PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2023-02-15 2022-12-31 13F VANDA PHARMACEUTICALS COM Call 13,200 98 n/a n/a n/a
2022-08-16 2022-06-30 13F VANDA PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2022-05-17 2022-03-31 13F VANDA PHARMACEUTICALS COM Call 11,400 -35.59 129 -53.60 n/a n/a n/a
2022-02-15 2021-12-31 13F VANDA PHARMACEUTICALS COM Call 17,700 62.39 278 48.66 n/a n/a n/a
2021-11-16 2021-09-30 13F VANDA PHARMACEUTICALS COM Call 10,900 -55.51 187 -64.52 n/a n/a n/a
2021-08-16 2021-06-30 13F VANDA PHARMACEUTICALS COM Call 24,500 527 n/a n/a n/a
2015-11-16 2015-09-30 13F VANDA PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2015-08-14 2015-06-30 13F VANDA PHARMACEUTICALS COM Call 10,700 136 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2022-02-15 2021-12-31 13F VANDA PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2021-11-16 2021-09-30 13F VANDA PHARMACEUTICALS COM Put 24,100 92.80 413 53.53 n/a n/a n/a
2021-08-16 2021-06-30 13F VANDA PHARMACEUTICALS COM Put 12,500 269 n/a n/a n/a
2018-08-15 2018-06-30 13F VANDA PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2018-05-15 2018-03-31 13F VANDA PHARMACEUTICALS COM Put 17,400 293 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.